The use of third-party service providers, so-called vendors, in the context of clinical trials of medicinal products for human use. BioLaw [Internet]. 2024 Oct. 17 [cited 2026 Jul. 7];(3):329-50. Available from: https://teseo-ojs35-test.archicoop.it/biolaw/article/view/3203